These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8874590)

  • 1. Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis.
    Fredrikson S
    Acta Neurol Scand; 1996 Jul; 94(1):31-4. PubMed ID: 8874590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis.
    Eckford SD; Swami KS; Jackson SR; Abrams PH
    Br J Urol; 1994 Dec; 74(6):733-5. PubMed ID: 7827843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis.
    Kinn AC; Larsson PO
    Scand J Urol Nephrol; 1990; 24(2):109-12. PubMed ID: 2192444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiuresis: a new concept in managing female daytime urinary incontinence.
    Robinson D; Cardozo L; Akeson M; Hvistendahl G; Riis A; Norgaard JP
    BJU Int; 2004 May; 93(7):996-1000. PubMed ID: 15142150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial.
    Valiquette G; Herbert J; Maede-D'Alisera P
    Arch Neurol; 1996 Dec; 53(12):1270-5. PubMed ID: 8970454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.
    Zahariou A; Karamouti M; Karagiannis G; Papaioannou P
    Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
    Bosma R; Wynia K; Havlíková E; De Keyser J; Middel B
    Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study. Dutch Enuresis Study Group.
    Janknegt RA; Zweers HM; Delaere KP; Kloet AG; Khoe SG; Arendsen HJ
    J Urol; 1997 Feb; 157(2):513-7. PubMed ID: 8996345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis.
    Hoverd PA; Fowler CJ
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):778-80. PubMed ID: 9810957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
    Hilton P; Hertogs K; Stanton SL
    J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):854-5. PubMed ID: 6619893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
    Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
    Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do independent geriatric outpatients with nocturnal polyuria profit from desmopressin?
    Weinrebe W; Käbe-Frisch S; Füsgen I; Karaman M; Johannsdottir E; Rupp S
    Z Gerontol Geriatr; 2019 May; 52(3):272-278. PubMed ID: 29541862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female.
    Hilton P; Stanton SL
    Br J Urol; 1982 Jun; 54(3):252-5. PubMed ID: 7049302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of renal colic with intranasal desmopressin spray.
    Constantinides C; Kapralos V; Manousakas T; Mitropoulos D; Alamanis C; Dimopoulos C
    Acta Urol Belg; 1998 Dec; 66(4):1-3. PubMed ID: 10083625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials.
    Kaminetsky J; Fein S; Dmochowski R; MacDiarmid S; Abrams S; Cheng M; Wein A
    J Urol; 2018 Sep; 200(3):604-611. PubMed ID: 29654805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
    Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hyponatremia due to desmopressin.
    Kelleher HB; Henderson SO
    J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ; Stokes A; Turner KL
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents.
    Stenberg A; Läckgren G
    Pediatrics; 1994 Dec; 94(6 Pt 1):841-6. PubMed ID: 7970999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of nocturnal enuresis with desmopressin intranasal spray.
    Uygur MC; Ozgü IH; Ozen H; Ozen S; Toklu C; Ergen A; Tekgül S; Remzi D
    Clin Pediatr (Phila); 1997 Aug; 36(8):455-9. PubMed ID: 9272319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.